| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Sana Biotechnology Inc (NASDAQ: SANA)
SANA Technical Analysis
5
| As on 9th Jun 2023 SANA STOCK Price closed @ 6.20 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 7.35 & Strong Sell for SHORT-TERM with Stoploss of 10.07 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SANASTOCK Price
| Open | 6.72 | Change | Price | % |
| High | 6.79 | 1 Day | -0.50 | -7.46 |
| Low | 6.15 | 1 Week | 0.18 | 2.99 |
| Close | 6.20 | 1 Month | 1.01 | 19.46 |
| Volume | 1015158 | 1 Year | -10.61 | -63.12 |
| 52 Week High 16.81 | 52 Week Low 3.11 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| SANA Daily Charts |
SANA Intraday Charts |
Whats New @ Bazaartrend |
SANA Free Analysis |
|
|
SANA Important Levels Intraday
| RESISTANCE | 7.43 |
| RESISTANCE | 7.04 |
| RESISTANCE | 6.79 |
| RESISTANCE | 6.55 |
| SUPPORT | 5.85 |
| SUPPORT | 5.61 |
| SUPPORT | 5.36 |
| SUPPORT | 4.97 |
SANA Forecast May 2024
| 4th UP Forecast | 23.49 |
| 3rd UP Forecast | 17.94 |
| 2nd UP Forecast | 14.52 |
| 1st UP Forecast | 11.09 |
| 1st DOWN Forecast | 1.31 |
| 2nd DOWN Forecast | -2.12 |
| 3rd DOWN Forecast | -5.54 |
| 4th DOWN Forecast | -11.09 |
SANA Weekly Forecast
| 4th UP Forecast | 9.69 |
| 3rd UP Forecast | 8.57 |
| 2nd UP Forecast | 7.88 |
| 1st UP Forecast | 7.19 |
| 1st DOWN Forecast | 5.21 |
| 2nd DOWN Forecast | 4.52 |
| 3rd DOWN Forecast | 3.83 |
| 4th DOWN Forecast | 2.71 |
SANA Forecast2024
| 4th UP Forecast | 32.79 |
| 3rd UP Forecast | 24.26 |
| 2nd UP Forecast | 18.99 |
| 1st UP Forecast | 13.72 |
| 1st DOWN Forecast | -1.32 |
| 2nd DOWN Forecast | -6.59 |
| 3rd DOWN Forecast | -11.86 |
| 4th DOWN Forecast | -20.39 |
Sana Biotechnology Inc ( NASDAQ USA Symbol : SANA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SANA Business Profile
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops in vivo and ex vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others. Its product candidates include SG295 and SG242 that target CD19+ cancer cells, including non-Hodgkin Lymphoma, chronic lymphocytic leukemia, and acute lymphoblastic leukemia; SG221 and SG239 for the treatment of multiple myeloma; and SG328 for ornithine transcarbamylase deficiency. It also develops SG418 for sickle cell disease and beta-thalassemia; SC291, a CD19 allogeneic T cell therapy; SC255 for multiple myeloma; SC451 for type I diabetes mellitus; SC379 for secondary progressive multiple sclerosis, Pelizaeus-Merzbacher disease, and Huntington's disease; and SC187 for heart failures. Sana Biotechnology, Inc. was formerly known as FD Therapeutics, Inc. and changed its name to Sana Biotechnology, Inc. in September 2018. The company was incorporated in 2018 and is headquartered in Seattle, Washington. Address: 188 East Blaine Street, Seattle, WA, United States, 98020
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service